Covista Inc.

NYSE:CVSA 株式レポート

時価総額:US$4.2b

Covista 将来の成長

Future 基準チェック /16

Covistaは、12%と7.1%でそれぞれ年率12%で利益と収益が成長すると予測される一方、EPSはgrowで14.4%年率。

主要情報

12.0%

収益成長率

14.41%

EPS成長率

Consumer Services 収益成長13.0%
収益成長率7.1%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日14 May 2026

今後の成長に関する最新情報

Recent updates

新しいナラティブ Apr 22

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

Catalysts About Covista Covista is a health care education provider focused on training nurses, physicians, veterinarians and behavioral health professionals at scale. What are the underlying business or industry changes driving this perspective?
新しいナラティブ Apr 08

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?
新しいナラティブ Mar 24

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

Catalysts About Covista Covista focuses on large scale health care education programs serving nursing, medical, veterinary and allied health students across the United States. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Mar 13

Covista: A Mispriced Bet On The Healthcare Worker Shortage

Summary Covista is trading significantly below its intrinsic value despite short-term headwinds at Chamberlain University. All segments are growing revenue; Walden University’s 27% revenue and 13% enrollment growth offset Chamberlain’s 1% enrollment decline. Key risks include heavy reliance on Title IV funding and regulatory changes, though long-term healthcare demand and AI-driven career shifts support growth and limit risk. Read the full article on Seeking Alpha
分析記事 Sep 27

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
分析記事 Aug 07

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

NYSE:ATGE 1 Year Share Price vs Fair Value Explore Adtalem Global Education's Fair Values from the Community and select...
分析記事 Jul 07

An Intrinsic Calculation For Adtalem Global Education Inc. (NYSE:ATGE) Suggests It's 44% Undervalued

Key Insights Adtalem Global Education's estimated fair value is US$221 based on 2 Stage Free Cash Flow to Equity...
分析記事 May 13

There's Reason For Concern Over Adtalem Global Education Inc.'s (NYSE:ATGE) Massive 27% Price Jump

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders have had their patience rewarded with a 27% share price jump...
分析記事 May 07

If EPS Growth Is Important To You, Adtalem Global Education (NYSE:ATGE) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 Apr 24

Is Adtalem Global Education (NYSE:ATGE) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 Mar 25

Adtalem Global Education Inc. (NYSE:ATGE) Shares Could Be 48% Below Their Intrinsic Value Estimate

Key Insights Adtalem Global Education's estimated fair value is US$198 based on 2 Stage Free Cash Flow to Equity...
分析記事 Mar 11

Subdued Growth No Barrier To Adtalem Global Education Inc.'s (NYSE:ATGE) Price

With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for...
分析記事 Feb 24

Is There Now An Opportunity In Adtalem Global Education Inc. (NYSE:ATGE)?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it saw a decent share price...
Seeking Alpha Feb 21

Adtalem Global Education: Surging On Registered Nurse Shortage

Summary Adtalem Global Education Inc.'s financial performance has surged with an underlying nationwide shortage of Registered Nurses and in mental health professionals. A shortage is expected to persist — Adtalem still looks to benefit from secular trends in an aging population, while the long-term performance depends on universities' ability to expand capacity. ATGE stock's surge already reflects a good mid-term earnings performance, making long-term growth required for significant returns. I estimate a fair value of $109.5. Read the full article on Seeking Alpha
分析記事 Jan 21

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 Dec 19

These 4 Measures Indicate That Adtalem Global Education (NYSE:ATGE) Is Using Debt Reasonably Well

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Dec 17

Adtalem Global Education Still Offers Competitive PEG Ratio And Substantial Share Buybacks

Summary The company has shown significant financial progress with improving EBIT and profit margins, indicating efficient cost management. Current valuation metrics suggest the company is rather cheaply priced, despite the good run in 2024. The future outlook remains positive, but investors should be aware of potential risks, such as the debt or future competitive threats from robotics. Read the full article on Seeking Alpha
分析記事 Nov 26

Adtalem Global Education Inc.'s (NYSE:ATGE) Shares Climb 27% But Its Business Is Yet to Catch Up

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders would be excited to see that the share price has had a great...
分析記事 Oct 31

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it led the NYSE gainers with a...
分析記事 Oct 16

Should You Be Adding Adtalem Global Education (NYSE:ATGE) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Seeking Alpha Oct 04

Adtalem Global Education Faces Problems But Is Growing Steadily

Summary Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue. With projected revenue growth and a forward P/E ratio of 13.12, Adtalem Global is a cautious buy, offering portfolio diversity in a growing sector. Read the full article on Seeking Alpha
分析記事 Sep 16

Adtalem Global Education (NYSE:ATGE) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 Aug 29

Adtalem Global Education Inc.'s (NYSE:ATGE) Price In Tune With Earnings

With a price-to-earnings (or "P/E") ratio of 20.7x Adtalem Global Education Inc. ( NYSE:ATGE ) may be sending bearish...
分析記事 Aug 14

We Think Adtalem Global Education's (NYSE:ATGE) Robust Earnings Are Conservative

Even though Adtalem Global Education Inc.'s ( NYSE:ATGE ) recent earnings release was robust, the market didn't seem to...
分析記事 Jul 28

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

While Adtalem Global Education Inc. ( NYSE:ATGE ) might not have the largest market cap around , it led the NYSE...
Seeking Alpha Jul 27

Adtalem Global Education: Still Undervalued After The Latest Rally

Summary Adtalem Global Education is set to report earnings on August 6th. The company specializes in healthcare education, with Chamberlain and Walden Universities under its wing, showing revenue growth post Walden acquisition. Financials show decent margins, but efficiency metrics trending down, with potential for top-line growth and margin expansion in the future. Read the full article on Seeking Alpha
分析記事 Jul 12

Does Adtalem Global Education (NYSE:ATGE) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
分析記事 Jun 14

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha May 19

Adtalem Global Education: A Leading Healthcare Educator In A Growing Industry

Summary ATGE has demonstrated robust revenue growth and strong profit margins over the past three years. ATGE's 3Q24 earnings showed year-over-year revenue growth of 11.8%, driven by growth in enrollment and tuition rates. The healthcare industry is facing significant labour shortages, which are expected to impact hospitals growth targets and outlook. ATGE plays a crucial role in training and providing healthcare professionals. Read the full article on Seeking Alpha

業績と収益の成長予測

NYSE:CVSA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
6/30/20282,2323243434442
6/30/20272,0622962973984
6/30/20261,9342492833574
3/31/20261,910250336406N/A
12/31/20251,889254368428N/A
9/30/20251,833247323379N/A
6/30/20251,788233288338N/A
3/31/20251,741229291338N/A
12/31/20241,688204234284N/A
9/30/20241,633172241290N/A
6/30/20241,585138247296N/A
3/31/20241,539111239278N/A
12/31/20231,496122196232N/A
9/30/20231,465108165196N/A
6/30/20231,451102166192N/A
3/31/20231,4477980108N/A
12/31/20221,442352551N/A
9/30/20221,447473161N/A
6/30/20221,382-36-2011N/A
3/31/20221,245-3566100N/A
12/31/20211,111-1595130N/A
9/30/2021977-26121153N/A
6/30/202189963152192N/A
3/31/2021943139106146N/A
12/31/2020984269141185N/A
9/30/20201,01624692140N/A
6/30/202086622068108N/A
3/31/20201,057208138182N/A
12/31/20191,04489N/A168N/A
9/30/20191,032130N/A174N/A
6/30/20191,014107N/A205N/A
3/31/20191,069169N/A184N/A
12/31/20181,121177N/A212N/A
9/30/20181,17584N/A227N/A
6/30/201896068N/A239N/A
3/31/20181,12467N/A244N/A
12/31/20171,14661N/A239N/A
9/30/20171,172119N/A222N/A
6/30/20171,208120N/A231N/A
3/31/20171,46759N/A178N/A
12/31/20161,60975N/A193N/A
9/30/20161,73117N/A210N/A
6/30/20161,080125N/A231N/A
3/31/20161,84537N/A213N/A
12/31/20151,86126N/A187N/A
9/30/20151,889119N/A179N/A
6/30/20151,910134N/A206N/A

アナリストによる今後の成長予測

収入対貯蓄率: CVSAの予測収益成長率 (年間12% ) は 貯蓄率 ( 3.5% ) を上回っています。

収益対市場: CVSAの収益 ( 12% ) US市場 ( 16.9% ) よりも低い成長が予測されています。

高成長収益: CVSAの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: CVSAの収益 ( 7.1% ) US市場 ( 11.9% ) よりも低い成長が予測されています。

高い収益成長: CVSAの収益 ( 7.1% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: CVSAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/05/27 08:16
終値2026/05/27 00:00
収益2026/03/31
年間収益2025/06/30

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Covista Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。23

アナリスト機関
Gary BisbeeBarclays
Alexander ParisBarrington Research Associates, Inc.
Jeffrey SilberBMO Capital Markets Equity Research